New York Life Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
New York Life Trust's ABBV Position: Q1 2017 in Review
New York Life Trust reduced its AbbVie (ABBV) stake by 94% in Q1 2017, selling an estimated $121K and leaving 126 shares worth $8K. The position accounts for 0.39% of the portfolio, ranked #76.
New York Life Trust first reported a position in ABBV in Q2 2013 and has held it in 16 quarters since. The position peaked at $199K in Q2 2014. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.
- New York Life Trust held 126 shares of AbbVie worth $8K as of Q1 2017.
- New York Life Trust sold 1,929 AbbVie shares in Q1 2017, an estimated $121K.
- AbbVie made up 0.39% of New York Life Trust's portfolio in Q1 2017, its #76 holding.
- New York Life Trust first reported a position in AbbVie in Q2 2013 and has held it in 16 quarters since.
- New York Life Trust's AbbVie position peaked at $199K in Q2 2014.
- 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.
Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.